Cognition and brain imaging in type 1 diabetes

Current Diabetes Reports

Volumn 8, Issue 2, 2008, Pages 132-137

  Musen, Gail ^a  

^a JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C; INOSITOL; N ACETYLASPARTIC ACID; OXYGEN; TAURINE;

BASAL GANGLION; BIOCHEMISTRY; BRAIN EDEMA; BRAIN OXYGEN TENSION; COGNITION; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DIABETIC KETOACIDOSIS; DIFFUSION TENSOR IMAGING; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; EVOKED VISUAL RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MEMORY DISORDER; MORPHOMETRICS; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONSET AGE; PSYCHOMOTOR RETARDATION; REVIEW; TASK PERFORMANCE; WHITE MATTER; ACUTE DISEASE; BRAIN; METABOLISM; PATHOLOGY; PSYCHOLOGICAL ASPECT;

ACUTE DISEASE; BRAIN; COGNITION; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; HUMANS; HYPOGLYCEMIA; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 44849134531     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-008-0024-z     Document Type: Review

References (54)

1. Brands AM, Biessels GJ, de Haan EH, et al.: The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 2005, 28:726-735.
2. Ryan CM: Neurobehavioral complications of type I diabetes. Examination of possible risk factors. Diabetes Care 1988, 11:86-93.
3. Northam EA, Anderson PJ, Werther GA, et al.: Neuropsychological complications of IDDM in children 2 years after disease onset. Diabetes Care 1998, 21:379-384.
4. Gold AE, Deary IJ, Frier BM: Recurrent severe hypoglycaemia and cognitive function in type 1 diabetes. Diabet Med 1993, 10:503-508.
5. Ryan CM, Williams TM, Finegold DN, Orchard TJ: Cognitive dysfunction in adults with type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. Diabetologia 1993, 36:329-334.
6. Ferguson SC, Blane A, Perros P, et al.: Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 2003, 52:149-156.
7. Ryan CM: Effects of diabetes mellitus on neuropsychological functioning: a lifespan perspective. Sem Clin Neuropsychiatry 1997, 2:4-14.
8. Northam EA, Anderson PJ, Jacobs R, et al.: Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care 2001, 24:1541-1546.
9. Kaufman FR, Epport K, Engilman R, Halvorson M: Neurocognitive functioning in children diagnosed with diabetes before age 10 years. J Diabetes Complications 1999, 13:31-38.
10. Rovet JF, Ehrlich RM: The effect of hypoglycemic seizures on cognitive function in children with diabetes: a 7-year prospective study. J Pediatr 1999, 134:503-506.
11. Northam EA, Anderson PJ, Werther GA, et al.: Predictors of change in the neuropsychological profiles of children with type 1 diabetes 2 years after disease onset. Diabetes Care 1999, 22:1438-1444.
12. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial [no authors listed]. Ann Intern Med 1996, 124:379-388.
13. Reichard P, Pihl M, Rosenqvist U, Sule J: Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up. Diabetologia 1996, 39:1483-1488.
14. Deary IJ, Frier BM: Severe hypoglycaemia and cognitive impairment in diabetes: link not proven. BMJ 1996, 313:767-768.
15. Jacobson AM, Musen G, Ryan CM, et al.: Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007, 356:1842-1852.
16. Ryan CM: Why is cognitive dysfunction associated with the development of diabetes early in life? The diathesis hypothesis. Pediatric Diabetes 2006, 7:289-297.
17. Ryan CM: Diabetes, aging, and cognitive decline. Neurobiol Aging 2005, 26(Suppl 1):21-25.
18. Ryan C, Geckle M, Orchard T: Cognitive efficiency declines over time in adults with type 1 diabetes: effects of micro-and macrovascular complications. Diabetologia 2003, 46:940-948.
19. Bolli GB: Treatment and prevention of hypoglycemia and its unawareness in type 1 diabetes meltitus. Rev Endocr Metab Disord 2003, 4:335-341.
20. Rosenthal JM, Amiel SA, Yaguez L, et al.: The effect of acute hypoglycemia on brain function and activation: a functional magnetic resonance imaging study. Diabetes 2001, 50:1618-1626.
21. Cox DJ, Penberthy JK, Zrebiec J, et al.: Diabetes and driving mishaps: frequency and correlations from a multinational survey. Diabetes Care 2003, 26:2329-2334.
22. Cryer PE: Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle. Diabetes 1992, 41:255-260.
23. Fanelli CG, Epifano L, Rambotti AM, et al.: Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993, 42:1683-1689.
24. Amiel SA: Cognitive function testing in studies of acute hypoglycaemia: rights and wrongs? Diabetologia 1998, 41:713-719.
25. Dejgaard A, Gade A, Larsson H, et al.: Evidence for diabetic encephalopathy. Diabet Med 1991, 8:162-167.
26. Seidl R, Birnbacher R, Hauser E, et al.: Brainstem auditory evoked potentials and visually evoked potentials in young patients with IDDM. Diabetes Care 1996, 19:1220-1224.
27. Hauser E, Strohmayer C, Seidl R, et al.: Quantitative EEG in young diabetics. J Child Neurol 1995, 10:330-334.
28. Uccioli L, Parisi V, Monticone G, et al.: Electrophysiological assessment of visual function in newly-diagnosed IDDM patients. Diabetologia 1995, 38:804-808.
29. Parisi V, Uccioli L: Visual electrophysiological responses in persons with type 1 diabetes. Diabetes Metab Res Rev 2001, 17:12-18.
30. Ziegler O, Guerci B, Algan M, et al.: Improved visual evoked potential latencies in poorly controlled diabetic patients after short-term strict metabolic control. Diabetes Care 1994, 17:1141-1147.
31. Lippe S, Roy MS, Perchet C, Lassonde M: Electrophysiological markers of visuocortical development. Cereb Cortex 2007, 17:100-107.
32. Wozniak JR, Lim KO: Advances in white matter imaging: a review of in vivo magnetic resonance methodologies and their applicability to the study of development and aging. Neurosci Biobehav Rev 2006, 30:762-774.
33. Bryan RN, Cai J, Burke G, et al.: Prevalence and anatomic characteristics of infarct-like lesions on MR images of middle-aged adults: the atherosclerosis risk in communities study. AJNR Am J Neuroradiol 1999, 20:1273-1280.
34. Perros P, Deary IJ, Sellar RJ, et al.: Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 1997, 20:1013-1018.
35. Brands AM, Kessels RP, Hoogma RP, et al.: Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes 2006, 55:1800-1806.
36. Weinger K, Jacobson AM, Musen G, et al.: The effects of type 1 diabetes on cerebral white matter. Diabetologia 2008, In press.
37. Wu J, Perantie DC, Sadler M, et al.: Pilot diffusion tensor imaging study in youth with type 1 diabetes mellitus reveals changes in white matter integrity associated with chronic hyperglycemia. Diabetes 2007, 56(Suppl):A477.
38. Baron JC, Chetelat G, Desgranges B, et al.: In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 2001, 14:298-309.
39. Musen G, Lyoo IK, Sparks CR, et al.: Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 2006, 55:326-333.
40. Wessels AM, Simsek S, Remijnse PL, et al.: Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 2006, 49:2474-2480.
41. Perantie DC, Wu J, Koller JM, et al.: Voxel-based morphometry detects brain volume changes due to hypo-and hyperglycemia in youth with type 1 diabetes mellitus. Diabetes 2007, 56(Suppl):A476.
42. Raichle ME, MacLeod AM, Snyder AZ, et al.: A default mode of brain function. Proc Natl Acad Sci U S A 2001, 98:676-682.
43. Gusnard DA, Raichle ME: Searching for a baseline: functional imaging and the resting human brain. Nat Rev Neurosci 2001, 2:685-694.
44. Wessels AM, Rombouts SA, Simsek S, et al.: Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study. Diabetes 2006, 55:334-340.
45. De Stefano N, Filippi M: MR spectroscopy in multiple sclerosis. J Neuroimaging 2007, 17:31S-35S.
46. Minati L, Grisoli M, Bruzzone MG: MR spectroscopy, functional MRI, and diffusion-tensor imaging in the aging brain: a conceptual review. J Geriatr Psychiatry Neurol 2007, 20:3-21.
47. Wolfsdorf J, Glaser N, Sperling MA: Diabetic ketoacidosis in infants, children, and adolescents: a consensus statement from the American Diabetes Association. Diabetes Care 2006, 29:1150-1159.
48. Muir AB, Quisling RG, Yang MC, Rosenbloom AL: Cerebral edema in childhood diabetic ketoacidosis: natural history, radiographic findings, and early identification. Diabetes Care 2004, 27:1541-1546.
49. Wootton-Gorges SL, Glaser NS: Imaging of the brain in children with type I diabetes mellitus. Pediatr Radiol 2007, 37:863-869.
50. Silver SM, Clark EC, Schroeder BM, Sterns RH: Pathogenesis of cerebral edema after treatment of diabetic ketoacidosis. Kidney Int 1997, 51:1237-1244.
51. Kreis R, Ross BD: Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology 1992, 184:123-130.
52. Cameron FJ, Kean MJ, Wellard RM, et al.: Insights into the acute cerebral metabolic changes associated with childhood diabetes. Diabet Med 2005, 22:648-653.
53. Pouwels PJ, Brockmann K, Kruse B, et al.: Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res 1999, 46:474-485.
54. Sarac K, Akinci A, Alkan A, et al.: Brain metabolite changes on proton magnetic resonance spectroscopy in children with poorly controlled type 1 diabetes mellitus. Neuroradiology 2005, 47:562-565.